BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:24th Pharmacovigilance 2021\n\n“Latest developments in pharmac ovigilance\, drug safety and RMP”\n\n24th - 25th February 2021\, Virtual Conference (Time Zone - GMT)\n\nThis conference will bring together top p harmaceutical\, biotechnology and regulatory representatives under one ro of that will address the key issues of the industry.\n\nDELEGATE REGISTRA TION:\n\nEmail: kavitha@virtueinsight.co.in or Call: +44-20 3509 3779\n\n Please note that this is a PAID event and NOT A FREE event (no compliment ary passes available). Any invite\, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.\n\nEarly Bird Pricing\n\ n1 Delegate @ £400 + VAT (Valid Till 28th January 2021)\n\n3 Delegates @ £1000 +VAT (Valid Till 28th January 2021)\n\nStandard Pricing\n\n1 Delega te @ £600 +VAT (Valid From 29th January 2021)\n\n3 Delegates @ £1400 + VA T (Valid From 29th January 2021)\n\nConference Sponsor\, Exhibition Stall &\; Paid Speaker Slot - Please email your interest and queries to kav itha@virtueinsight.co.in .\n\nKEY SPEAKERS:\n\n\nWILLIAM WANG\, Executive Director\, Clinical Safety Statistics\, Merck (USA)\nMICHAEL BEAN\, Seni or Director\, Regulatory Compliance R&\;D\, Johnson &\; Johnson\nWI VINA DE WAELE\, Director\, Regional Safety Excellence EMEA. Global Drug S afety\, Alexion Pharmaceuticals\nKHAUDEJA BANO\, Executive Medical Direct or\, Combination Product Safety Head\, Amgen (USA)\nSUMIT MUNJAL\, Vice P resident\, Global Patient Safety Evaluation\, Takeda\nJOHN SOLOMON\, Head of Pharmacovigilance - UK &\; Ireland\, Sanofi\nOYINKANSOLA ODEBO\, A ssistant Director\, Drug Safety Clinical Research\, Supernus Pharmaceutic als (USA)\nALESSANDRO VAGHEGGINI\, Associate Principal Biostatistician\, Clinical Safety Statistics\, Merck (USA)\nTEA BABIC\, Dir – Audits and I nspections\, Teva\nDAVID J LEWIS\, EU QPPV Head QPPV Office\, Novartis\nS HAUN COMFORT\, Principal Scientific Enablement Director\, Roche – Genente ch\nYUUNG YUUNG YAP\, Senior International Regulatory Counsel\, EU and In ternational Regulatory Law\, Pfizer\nDAVID JEFFERYS\, VP Regulatory\, Ei sai\nVALENTINA MANCINI\, Director PV\, EU QPPV\, Shionogi Europe\nROSALIN A DOMIN\, Senior Director\, QA and Deviation Management Head\, PV Quality \, Sanofi\nRAJ BHOGAL\, Director\, R&\;D Audits &\; Inspections\, Jazz Pharmaceuticals\nANDREA OLIVA\, Head of Pharmacovigilance\, Mylan\nJ AYLAXMI NALAWADE\, Associate Director - Pharmacovigilance &\; REMS\, L upin\nFRANCK SCHWARTZ\, QA Global Inspection\, Intelligence Lead - Compli ance &\; Regulatory Affairs Quality\, Novartis\nYVONNE NANCIU\, Senior Manager Pharmacovigilance &\; Medical Information\, Local QPPV\, Abbv ie\nRUDI SCHEERLINCK\, Global Head Pharmacovigilance Risk Management\, Ne stle\nCHETAN SHATAPATHY\, Principal Pharamcovigilance Physician - Oncolog y R&\;D Unit\, AstraZeneca\nJOHN POUSTIE\, Senior Director\, Global Ph armacovigilance\, Norgine\nSUE REES\, Pharmacovigilance Expert\, (Former EU QPPV Executive Director\, Global Safety)\, Amgen\nGAURI UTTURKAR\, Sen ior Manager - Pharmacovigilance\, Glenmark Pharmaceuticals\nLISBETH TOFTE HEMMINGSEN\, Director\, Drug Safety Consult\nNICOLE BAKER\, Co-Founder\, BioLogit\nMARY LYNNE VAN POELGEEST\, President\, World Federation for In continent Patients -(WFIP)\n\nPlus more joining soon\n\nFOCUSES ON:\n\n\n Overcoming this Pandemic Issues - Drug Safety Strategy for Pharmaceutical organisations\nOutsourcing in Pharmacovigilance- Best Practices\, Challe nges and key consideration\nKey factors driving the current global Pharma covigilance (PV) market?\nPharmacovigilance and assessment of drug safety reports during COVID 19\nWhat are the market opportunities\, market risk and market overview of the (PV) market?\nPV Audit &\; Inspections – K eeping on the right side of Inspectors\nDocumentation (RMPs\, PSURs\, PAD ERs\, PBRERs)\nPractical approaches - Quality\, Safety &\; Signal Dete ction \; \; \;\nMedical devices – Increasing safety perspecti ve\nImproving patient safety\nNew Technologies in Pharmacovigilance (AI/ Machine Learning\, IoT)\nBrexit Implications for the Pharmaceutical (phar macovigilance) Industry\nRoW - Recent developments and future perspective s\nThe developing regulatory framework in advanced and developing markets – EU\, USA &\; ROW\nBe part of a major networking opportunity\n\nGet more from the event\, with a broader scope bringing the whole communicati ons value chain together. Enjoy and make the best out of our dedicated ne tworking drinks time\, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition.\n\n \;\n\n&nbs p\;\n DTEND:20210225T173000 DTSTAMP:20260512T214303Z DTSTART:20210224T093000 LOCATION:\, SEQUENCE:0 SUMMARY:24th Pharmacovigilance 2021\n“Latest developments in pharmacovigil ance\, drug safety and RMP”\n24th - 25th February 2021\, Virtual Conferen ce (Time Z... UID:fbdd1232-56af-4492-84d0-4f7c84700eae END:VEVENT END:VCALENDAR